Eric Fujimura
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 10%
Papers in
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 detection and testing 1
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Julie Anne Zorn (1 shared paper)Qi Wang (1 shared paper)John Kuriyan (1 shared paper)Tiago F. Barros (1 shared paper)Stephen J. Elledge (3 shared papers)Zuzana Tóthová (1 shared paper)Emily C. Wheeler (1 shared paper)Timothy D. Martin (1 shared paper)
- Journals
- Science (3 papers)Proceedings of the National Academy of Sciences (1 paper)PLoS ONE (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Eric Fujimura
5 papers receiving 718 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 422
- Modeling and Simulation 37
- Hematology 74
- Animal Science and Zoology 62
- Immunology 116
Countries citing papers authored by Eric Fujimura
This map shows the geographic impact of Eric Fujimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Fujimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Fujimura more than expected).
Fields of papers citing papers by Eric Fujimura
This network shows the impact of papers produced by Eric Fujimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Fujimura. The network helps show where Eric Fujimura may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Fujimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 481 | |
| 2 | 2015 | 98 | |
| 3 | 2021 | 68 | |
| 4 | 2023 | 56 | |
| 5 | 2022 | 31 | |
| 6 | 2026 | 0 |
About Eric Fujimura
Eric Fujimura is a scholar working on Infectious Diseases, Immunology, Genetics, Hematology and Molecular Biology, having authored 6 papers that have together received 734 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Ferroptosis and cancer prognosis (1 paper), COVID-19 Clinical Research Studies (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), vaccines and immunoinformatics approaches (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and SARS-CoV-2 detection and testing (1 paper). The work is most often cited by research in Infectious Diseases (422 citations), Modeling and Simulation (37 citations), Hematology (74 citations), Animal Science and Zoology (62 citations) and Immunology (116 citations). Eric Fujimura has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Julie Anne Zorn, Qi Wang, John Kuriyan, Tiago F. Barros, Stephen J. Elledge, Zuzana Tóthová, Emily C. Wheeler, Timothy D. Martin, Kristen E. Mengwasser and Benjamin E. Gewurz. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.